Anne Wojcicki (Photographer: Jordan Vonderhaar/Bloomberg via Getty Images)
July 14, 2025 12:05 PM EDT
Deals
Health Tech

Af­ter long saga, 23and­Me's deal with Anne Wo­j­ci­ck­i's non­prof­it fi­nal­ly clos­es

Lydia Ramsey Pflanzer

Deputy Editor

At long last, Anne Wo­j­ci­c­ki has of­fi­cial­ly bought 23andMe.

The co-founder and for­mer CEO’s non­prof­it, TTAM Re­search In­sti­tute, on Mon­day said it had com­plet­ed the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA chief calls for low­er user fees as ne­go­ti­a­tions be­gin for eighth round of PDU­FA

23andMe files for bank­rupt­cy, CEO Wo­j­ci­c­ki steps down

Re­gen­eron plans to buy 23andMe for $256M

23and­Me's CEO files plan to take com­pa­ny pri­vate

FDA de­clines to ap­prove Ul­tragenyx's San­fil­ip­po gene ther­a­py, cit­ing man­u­fac­tur­ing is­sues

As­traZeneca posts a piv­otal tri­al win for blood pres­sure pill be­hind $1.3B deal

A service from the Financial Times